WANY
NUVB icon

Wealthspire Advisors (New York)’s Nuvation Bio NUVB Stock Holding History

Wealthspire Advisors (New York)’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,000
Closed -$7.4K – 2258
2025
Q3 		$7.4K Buy
+2,000
New +$5.45K ﹤0.01% 2167

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Wealthspire Advisors (New York)'s NUVB Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 2,000 shares — an estimated $7.4K sold.

Wealthspire Advisors (New York) first reported a position in NUVB in Q3 2025 and held it in 1 quarter. The position peaked at $7.4K in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 2,000 Nuvation Bio shares in Q4 2025, an estimated $7.4K.
  • Wealthspire Advisors (New York) first reported a position in Nuvation Bio in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Nuvation Bio position peaked at $7.4K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.